Lemaitre Vascular (LMAT) Enterprise Value (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Enterprise Value of -$367.2 million for Q1 2026, down 21.38% year-over-year from -$467.1 million in Q1 2025, and down 2.26% quarter-over-quarter from -$359.1 million in Q4 2025.
Lemaitre Vascular (LMAT) Enterprise Value (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Enterprise Value for 17 consecutive years, with -$367.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 21.38% year-over-year to -$367.2 million; the TTM figure through Mar 2026 stood at -$367.2 million (down 21.38% YoY), while the FY2025 annual figure was -$359.1 million, down 19.82% from the prior year.
- Enterprise Value declined to -$367.2 million in Q1 2026 per LMAT's latest filing, from -$359.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$70.9 million in Q1 2022 and bottomed at -$367.2 million in Q1 2026.
- Historically, Enterprise Value has averaged -$177.6 million across 5 years, with a median of -$108.3 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 247.87% — and 2023, when it decreased 14.28%.
- Lemaitre Vascular's Enterprise Value stood at -$82.7 million in 2022, then dropped by 27.07% to -$105.1 million in 2023, then slumped by 185.25% to -$299.7 million in 2024, then slipped by 19.82% to -$359.1 million in 2025, then slipped by 2.26% to -$367.2 million in 2026.
- Business Quant data shows LMAT's Enterprise Value at -$367.2 million in Q1 2026, -$359.1 million in Q4 2025, and -$343.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | -376.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -376.24 Mn |
| Mar 31, 2026 | -367.23 Mn |
| Dec 31, 2025 | -359.12 Mn |
| Sep 30, 2025 | -343.06 Mn |
| Jun 30, 2025 | -319.49 Mn |
| Mar 31, 2025 | -302.55 Mn |
| Dec 31, 2024 | -299.72 Mn |
| Sep 30, 2024 | -123.89 Mn |
| Jun 30, 2024 | -113.10 Mn |
| Mar 31, 2024 | -108.29 Mn |
| Dec 31, 2023 | -105.07 Mn |
| Sep 30, 2023 | -97.02 Mn |
| Jun 30, 2023 | -90.18 Mn |
| Mar 31, 2023 | -81.01 Mn |
| Dec 31, 2022 | -82.69 Mn |
| Sep 30, 2022 | -79.74 Mn |
| Jun 30, 2022 | -75.68 Mn |
| Mar 31, 2022 | -70.88 Mn |
| Dec 31, 2021 | -69.96 Mn |
| Sep 30, 2021 | -67.08 Mn |